What is TytoCare?
TytoCare operates at the intersection of artificial intelligence and clinical diagnostics, providing a comprehensive platform that enables health systems, payers, and care programs to deliver high-fidelity remote care. By integrating FDA-cleared handheld diagnostic hardware with sophisticated AI-powered Software as a Medical Device (SaMD) algorithms, the company facilitates clinical-grade examinations across primary care, cardiopulmonary, and oncology pathways. Headquartered in New York and Netanya, Israel, TytoCare has established itself as a foundational technology partner for global health organizations seeking to bridge the gap between in-person and virtual care delivery models.
How much funding has TytoCare raised?
TytoCare has raised a total of $233.3M across 7 funding rounds:
Series A
$4M
Series B
$11M
Series C
$35.3M
Other Financing Round
$9M
Series D
$100M
Other Financing Round
$49M
Private Equity
$25M
Series A (2014): $4M with participation from OrbiMed and LionBird
Series B (2015): $11M led by Walgreens, OrbiMed, and LionBird
Series C (2019): $35.3M supported by Sanford Health, Shenzhen Capital Group, Ping An Global Voyager, and Itochu
Other Financing Round (2019): $9M, investors not publicly disclosed
Series D (2021): $100M backed by Shenzhen Capital Group, Qualcomm Ventures LLC, TriplePoint Venture Growth BDC, Qumra Capital, Olive Tree Ventures, and The Insight Partners
Other Financing Round (2023): $49M with participation from Insight Partners, MemorialCare, HOOPP, and Clal Insurance
Private Equity (2026): $25M led by Insight Partners, OrbiMed, Qumra Capital, Qualcomm Ventures, and Olive Tree Ventures
Key Investors in TytoCare
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies, providing capital and hands-on operational support to help businesses scale from early stage to IPO.
OrbiMed
OrbiMed Advisors LLC is a specialized investment firm focused on the healthcare sector, managing capital across biopharmaceuticals, medical devices, and digital health platforms with deep expertise in life sciences.
Qumra Capital
Qumra Capital is an Israel-based venture capital fund that focuses on late-stage technology companies with proven market fit, providing strategic support to help hypergrowth firms scale into global market leaders.
What's next for TytoCare?
The recent infusion of capital positions TytoCare to accelerate its enterprise-level expansion and deepen its technological moat. As the company transitions through its current lifecycle stage, the focus is expected to shift toward broader international market penetration and the enhancement of its AI diagnostic capabilities. By leveraging the strategic support of its investor base, TytoCare is well-positioned to capitalize on the growing demand for integrated, data-driven remote care solutions, potentially setting new standards for clinical efficacy and operational efficiency in the global healthcare market.
See full TytoCare company page
